Governor Abbott Signed Yet Another Restrictive Texas Abortion Ban Into Law

Earlier this month a restrictive Texas abortion law went into effect that essentially bans abortions after six weeks. Now Governor Greg Abbott just signed another state abortion law—one that bans the use of medication abortion after seven weeks, Forbes reports.

The new law, SB 4, heavily restricts the use and distribution of abortion pills and will go into effect on December 2, barring any legal interference. For starters, SB 4 makes it illegal for a health care provider to prescribe abortion pills to a pregnant person after 49 days of pregnancy (seven weeks), which is less than the 70 days (10 weeks) the Food and Drug Administration (FDA) allows. 

On top of that, the new legislation also makes it illegal to provide patients with abortion pills by mail, delivery service, or courier. In order to receive a medication abortion in Texas within the legal time frame, patients must now undergo an in-person examination and extensive informed consent process—even while in the midst of the COVID-19 pandemic.

What’s commonly known as the abortion pill is actually two medications: First, there’s mifepristone (also called Mifeprex or RU-486). This medication begins the termination process. Then, a day or two later, comes misoprostol, which helps the uterus push the pregnancy out. 

These medications are used to safely end pregnancies before 10 weeks. Research suggests they’re safe to use even when prescribed via telemedicine. They do come with the risk for some side effects, such as cramps, bleeding, and nausea, and in rare cases (about 0.3%), they can lead to excessive bleeding or other issues that require hospitalization. But they’re generally considered quite safe medications.

Despite its safety profile, mifepristone is regulated by a Risk Evaluation and Mitigation Strategy (REMS) from the FDA, which prohibits pharmacies from dispensing the medication. The medication can be prescribed only by certain health care providers and can be given to patients only in clinics, hospitals, or doctor’s offices under the supervision of a health care provider. Some states also require the doctor to be physically in the room with the patient while they take mifepristone, the Guttmacher Institute explains

During the pandemic though, an FDA investigation did not find any increase in medication abortion-related complications when it decided not to enforce the requirement for an in-person visit to access the medications. So the new Texas medication abortion ban is yet another law that restricts access to safe, necessary health care. And even for those who can still access medication abortion in Texas, the legislation will add unnecessary barriers that make doing so even harder in the middle of an ongoing pandemic.

Related:

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Goodbye, Appendix. Hello, Crohn's Disease? thumbnail

Goodbye, Appendix. Hello, Crohn’s Disease?

Meeting Coverage > AIBD — Meta-analysis finds a possible connection, although high heterogeneity was an issue by Ed Susman, Contributing Writer, MedPage Today December 17, 2023 ORLANDO – People who undergo appendectomy may have an increased risk for the development of Crohn's disease (CD), but not ulcerative colitis (UC), according to a systematic review and
Read More
9 Tips to Reduce Food Poisoning Risk During a Picnic thumbnail

9 Tips to Reduce Food Poisoning Risk During a Picnic

It’s that time of year when folks suddenly want to do everything outside—including eating. And what better way to do so than at a picnic? Nothing feels more summery than whipping out a blanket and piling it high with alfresco fixings like tasty sandwiches and refreshing drinks.But that scene turns a little less blissful when you add
Read More
Researchers test new E. coli approach to help risk management thumbnail

Researchers test new E. coli approach to help risk management

A new approach could improve risk management decisions around Shiga toxin-producing E. coli (STEC), according to a study. Risk classification and management of STEC isolated from food has been hampered by gaps in knowledge about how different types can cause severe disease.  In 2019, a joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA) proposed
Read More
Index Of News
Total
0
Share